| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Davide Cacchiarelli, Ivano Legnini, Julie Martone, Valentina Cazzella, Adele D'Amico, Enrico Bertini, Irene Bozzon. miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO molecular medicine. vol 3. issue 5. 2011-08-09. PMID:21425469. |
even though creatine kinase (ck) blood levels have been utilized as diagnostic markers of several neuromuscular diseases, including dmd, we demonstrate that they correlate less well with the disease severity. |
2011-08-09 |
2023-08-12 |
mouse |
| A T J M Helderman-van den Enden, J C van den Bergen, M H Breuning, J J G M Verschuuren, A Tibben, E Bakker, H B Ginjaa. Duchenne/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level? Clinical genetics. vol 79. issue 3. 2011-05-24. PMID:21070212. |
duchenne muscular dystrophy (dmd) is the most common inherited neuromuscular disease. |
2011-05-24 |
2023-08-12 |
Not clear |
| Thomas Sejerson, Kate Bushb. Standards of care for Duchenne muscular dystrophy: brief TREAT-NMD recommendations. Advances in experimental medicine and biology. vol 652. 2010-04-02. PMID:20225016. |
a worldwide effort is underway to generate care guidelines for dmd, which involves the centre for disease control in the usa and the treat-nmd network of excellence for neuromuscular diseases in europe. |
2010-04-02 |
2023-08-12 |
Not clear |
| Benjamin Koo, Jacqueline Montes, Viktor Gamarnik, Keith Yeager, Jonathan Marra, Sally Dunaway, Megan Montgomery, Darryl C De Vivo, Nancy Strauss, Elisa Konofagou, Petra Kaufmann, Barclay Morriso. Design and evaluation of a hybrid passive and active gravity neutral orthosis (GNO). Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. vol 2009. 2010-03-25. PMID:19963513. |
neuromuscular diseases (nmd), including spinal muscular atrophy (sma) and duchenne muscular dystrophy (dmd), result in progressive muscular weakness that often leaves patients functionally dependent on caregivers for many activities of daily living (adl) such as eating, bathing, grooming (touching the face and head), reaching (grabbing for objects), and dressing. |
2010-03-25 |
2023-08-12 |
Not clear |
| L B López-Hernández, N A Vázquez-Cárdenas, E Luna-Padró. [Duchenne muscular dystrophy: current aspects and perspectives on treatment]. Revista de neurologia. vol 49. issue 7. 2009-12-16. PMID:19774532. |
duchenne muscular dystrophy (dmd) is a severe neuromuscular disease of genetic origin that affects male children. |
2009-12-16 |
2023-08-12 |
Not clear |
| Jainn-Jim Lin, Mao-Sheng Hwang, Shao-Hsuan Hsia, Hung-Tao Chung, Yu-Sheng Chang, Kuang-Lin Li. Pericardial effusion with cardiac tamponade as a cardiac manifestation of Duchenne muscular dystrophy. Muscle & nerve. vol 40. issue 3. 2009-10-06. PMID:19623636. |
duchenne muscular dystrophy (dmd) is the most common hereditary neuromuscular disease in children. |
2009-10-06 |
2023-08-12 |
Not clear |
| Raffaella Willmann, Stefanie Possekel, Judith Dubach-Powell, Thomas Meier, Markus A Rueg. Mammalian animal models for Duchenne muscular dystrophy. Neuromuscular disorders : NMD. vol 19. issue 4. 2009-07-28. PMID:19217290. |
duchenne muscular dystrophy (dmd) is a fatal neuromuscular disease that affects boys and leads to early death. |
2009-07-28 |
2023-08-12 |
Not clear |
| Raffaella Willmann, Stefanie Possekel, Judith Dubach-Powell, Thomas Meier, Markus A Rueg. Mammalian animal models for Duchenne muscular dystrophy. Neuromuscular disorders : NMD. vol 19. issue 4. 2009-07-28. PMID:19217290. |
in the frame of "treat-nmd", a european network of excellence addressing the fragmentation in the assessment and treatment of neuromuscular diseases, we compare here the currently used mammalian animal models for dmd with the aim of selecting and recommending the most appropriate ones for preclinical efficacy testing of new therapeutic strategies. |
2009-07-28 |
2023-08-12 |
Not clear |
| Jachinta E Rooney, Praveen B Gurpur, Dean J Burki. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America. vol 106. issue 19. 2009-06-22. PMID:19416897. |
duchenne muscular dystrophy (dmd) is a devastating neuromuscular disease caused by mutations in the gene encoding dystrophin. |
2009-06-22 |
2023-08-12 |
mouse |
| Bryan C Werner, Andrew J Skalsky, Craig M McDonald, Jay J Ha. Convexity of scoliosis related to handedness in identical twin boys with Duchenne's muscular dystrophy: a case report. Archives of physical medicine and rehabilitation. vol 89. issue 10. 2008-11-18. PMID:18929032. |
the unique clinical presentation of progressive neuromuscular disease and scoliosis in monozygotic twins should allow for a unique evaluation of some of the contributory factors associated with the development of neuromuscular scoliosis in dmd. |
2008-11-18 |
2023-08-12 |
Not clear |
| M Schoeffler, F Wallet, M O Robert, G Tramoni, S Workineh, J P Viale, S Duperre. [Increased troponin I level in a Duchenne muscular dystrophy patient with normal coronarography]. Annales francaises d'anesthesie et de reanimation. vol 27. issue 4. 2008-09-15. PMID:18468552. |
duchenne muscular dystrophy (dmd) is a neuromuscular disease characterized by a progressive skeletal muscular weakness. |
2008-09-15 |
2023-08-12 |
Not clear |
| Lu-Lu Xiao, Wei Chen, Cheng Zhang, Zhuo-Lin Liu, Xin Ye, Wei-Dong Zhang, Yan Y. [A probability analysis for HLA matching in adult stem cell transplantation treating nervous genetic diseases]. Zhongguo shi yan xue ye xue za zhi. vol 12. issue 6. 2008-08-25. PMID:15631675. |
it is concluded that stem cells transplantation therapy for dmd patients is feasible, which will benefit these patients suffered from the lethal neuromuscular disease, and create a new way to treat this tough nervous system disease. |
2008-08-25 |
2023-08-12 |
Not clear |
| S S Bhat, K R Schmidt, S Ladd, K C Kim, C E Schwartz, R J Simensen, B R DuPont, R E Stevenson, A K Srivastav. Disruption of DMD and deletion of ACSL4 causing developmental delay, hypotonia, and multiple congenital anomalies. Cytogenetic and genome research. vol 112. issue 1-2. 2006-02-03. PMID:16276108. |
these findings suggest that the disruption of dmd and the absence of acsl4 in the patient are responsible for neuromuscular disease and cognitive impairment. |
2006-02-03 |
2023-08-12 |
Not clear |
| Sadasivam Suresh, Patricia Wales, Carolyn Dakin, Margaret-Anne Harris, David Gus M Coope. Sleep-related breathing disorder in Duchenne muscular dystrophy: disease spectrum in the paediatric population. Journal of paediatrics and child health. vol 41. issue 9-10. 2006-01-26. PMID:16150067. |
duchenne muscular dystrophy (dmd) is a progressive neuromuscular disease with death usually occurring because of respiratory failure. |
2006-01-26 |
2023-08-12 |
Not clear |
| Simona Zanotti, Tiziana Negri, Cristina Cappelletti, Pia Bernasconi, Eleonora Canioni, Claudia Di Blasi, Elena Pegoraro, Corrado Angelini, Patrizia Ciscato, Alessandro Prelle, Renato Mantegazza, Lucia Morandi, Marina Mor. Decorin and biglycan expression is differentially altered in several muscular dystrophies. Brain : a journal of neurology. vol 128. issue Pt 11. 2005-11-28. PMID:16183658. |
we examined muscle biopsies from nine dmd patients, aged 2-8 years; 14 bmd (becker muscular dystrophy) patients (nine aged 1-5 years; five aged 30-37 years); four mdc1a patients (aged 2-7 years); six dysferlin-deficient patients (aged 19-53 years) with mutation ascertained in two, and normal expression of proteins related to limb girdle muscular dystrophies in the others; 10 sarcoglycan-deficient patients: seven with alpha-sarcoglycan mutation, two with beta-sarcoglycan mutation and one with gamma-sarcoglycan mutation (five aged 8-15 years; five aged 26-43 years); and nine children (aged 1-6 years) and 12 adults (aged 16-61 years) suspected of neuromuscular disease, but who had normal muscle on biopsy. |
2005-11-28 |
2023-08-12 |
Not clear |
| David Touboul, Hélène Piednoël, Vincent Voisin, Sabine De La Porte, Alain Brunelle, Frédéric Halgand, Olivier Laprévot. Changes of phospholipid composition within the dystrophic muscle by matrix-assisted laser desorption/ionization mass spectrometry and mass spectrometry imaging. European journal of mass spectrometry (Chichester, England). vol 10. issue 5. 2005-01-04. PMID:15531799. |
duchenne muscular dystrophy (dmd) is a neuromuscular disease linked to the lack of the dystrophin, a submembrane protein, leading to muscle weakness and associated with a defect of the lipid metabolism. |
2005-01-04 |
2023-08-12 |
mouse |
| Thomas O B Krag, Sasha Bogdanovich, Claus J Jensen, M Dominik Fischer, Jacob Hansen-Schwartz, Elisabeth H Javazon, Alan W Flake, Lars Edvinsson, Tejvir S Khuran. Heregulin ameliorates the dystrophic phenotype in mdx mice. Proceedings of the National Academy of Sciences of the United States of America. vol 101. issue 38. 2004-12-03. PMID:15365169. |
duchenne's muscular dystrophy (dmd) is a fatal neuromuscular disease caused by absence of dystrophin. |
2004-12-03 |
2023-08-12 |
mouse |
| Florencia Giliberto, Verónica Ferreiro, Viviana Dalamón, Ezequiel Surace, Javier Cotignola, Sebastián Esperante, Daniel Borelina, Sergio Baranzini, Irene Szija. Direct deletion analysis in two Duchenne muscular dystrophy symptomatic females using polymorphic dinucleotide (CA)n loci within the dystrophin gene. Journal of biochemistry and molecular biology. vol 36. issue 2. 2004-01-12. PMID:12689516. |
duchenne muscular dystrophy (dmd) is the most common hereditary neuromuscular disease. |
2004-01-12 |
2023-08-12 |
human |
| Isabelle Courdier-Fruh, Lee Barman, Philipp Wettstein, Thomas Meie. Detection of glucocorticoid-like activity in traditional Chinese medicine used for the treatment of Duchenne muscular dystrophy. Neuromuscular disorders : NMD. vol 13. issue 9. 2003-12-16. PMID:14561491. |
anecdotal reports of positive influence of certain traditional chinese medicines on the progression of neuromuscular diseases in general and duchenne muscular dystrophy (dmd) in particular has raised interest in patient support groups and clinical experts alike. |
2003-12-16 |
2023-08-12 |
human |
| S Pradha. Valley sign in duchenne muscular dystrophy: importance in patients with inconspicuous calves. Neurology India. vol 50. issue 2. 2002-08-14. PMID:12134184. |
the new sign was examined by 3 independent observers in these 12 dmd patients and in 10 patients with other neuromuscular diseases. |
2002-08-14 |
2023-08-12 |
Not clear |